|
|
Article: India: Novartis Venture Funds Eyes India Deals.
- Article from:
- TendersInfo
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: shiv03
The corporate biotech-venture investor is now looking for local partners in India.
Religare Labs In A Rs 200 Cr IPO - Diagnostic chain Super Religare Laboratories, owned by former promoters of Ranbaxy Labs, is planning to dilute 15-20% stake to raise Rs 200 crore through an initial public offer (IPO). The company has a valuation of Rs 1,000 crore and is in talks for a pre-IPO round. The firm was last year in talks for a PE round with ICICI Venture, Yes Bank, GM Financial and Standard Chartered, which was put on hold. SRL plans to invest Rs 300 crore towards its expansion plans in next 18 months. (Economic Times)
Jaypee Infratech ...